Pfizer's Rimegepant is first and only medicine approved for acute, preventive migraine treatment
Pfizer Philippines recently announced the availability of Rimegepant, a calcitonin gene-related peptide (CGRP) receptor antagonist, for both the acute treatment of migraine and the preventive treatment of episodic migraine in adults who have at least four migraine attacks per month. More than one billion people worldwide live with migraine and…
Source: businessmirror.com.ph